Atıf İçin Kopyala
Yilmaz B., Koseoglu H., Coskun Y., Deveci M., Kekilli M.
GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, cilt.13, sa.2, ss.150-156, 2018 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
13
Sayı:
2
-
Basım Tarihi:
2018
-
Doi Numarası:
10.5114/pg.2018.72732
-
Dergi Adı:
GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), Scopus
-
Sayfa Sayıları:
ss.150-156
-
Anahtar Kelimeler:
Helicobacter pylori eradication, clarithromycin resistance, STANDARD TRIPLE THERAPY, SEQUENTIAL THERAPY, ANTIBIOTIC-RESISTANCE, QUADRUPLE THERAPY, INFECTION, BISMUTH, MANAGEMENT, EFFICACY, TRIAL, AMOXICILLIN
-
Gazi Üniversitesi Adresli:
Hayır
Özet
Introduction: Helicobacter pylori infection is encountered in more than 50% of the world population. A high rate of clarithromycin resistance is observed among Helicobacter pylori strains in some regions because clarithromycin is a drug commonly used for the treatment of other infections.